Markus Moehler
马库斯·默勒
MD, PhD
Professor and Head, Department of Internal Medicine I (GI Oncology)内科I科（消化肿瘤）系主任及教授
👥Biography 个人简介
Markus Moehler, MD, PhD is Professor and Head of GI Oncology at University Medical Center Mainz and a key European clinical trialist across gastrointestinal and biliary tract cancers. He has contributed to major phase III immunotherapy trials in GI oncology including CheckMate 649, and has established Mainz as a leading center for biliary tract cancer clinical research in Germany.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Immunotherapy in GI and Biliary Tract Cancers
Led and contributed to multiple phase III trials of PD-1/PD-L1 inhibitors in gastric, gastroesophageal, and biliary tract cancers, advancing immunotherapy as a therapeutic cornerstone across GI malignancies.
European Biliary Tract Cancer Clinical Research
Established and directed clinical trial infrastructure at Mainz for biliary tract cancer studies, enrolling patients in key international trials and contributing to European GI oncology consortium efforts.
Representative Works 代表性著作
Nivolumab plus chemotherapy versus chemotherapy as first-line treatment for advanced gastric cancer/GEJ cancer (CheckMate 649)
The Lancet (2021)
Phase III trial establishing nivolumab plus chemotherapy as a new first-line standard in advanced gastric/GEJ cancer, with Moehler as a key contributing investigator.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 马库斯·默勒 的研究动态
Follow Markus Moehler's research updates
留下邮箱，当我们发布与 Markus Moehler（University Medical Center Mainz (Johannes Gutenberg University)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment